241 related articles for article (PubMed ID: 10425384)
21. Absorption enhancing effects of chitosan oligomers on the intestinal absorption of low molecular weight heparin in rats.
Zhang H; Mi J; Huo Y; Huang X; Xing J; Yamamoto A; Gao Y
Int J Pharm; 2014 May; 466(1-2):156-62. PubMed ID: 24614577
[TBL] [Abstract][Full Text] [Related]
22. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
23. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism.
Mudra DR; Borchardt RT
J Pharm Sci; 2010 Feb; 99(2):1016-27. PubMed ID: 19650119
[TBL] [Abstract][Full Text] [Related]
24. Loss of the intestinal mucus layer in the normal rat causes gut injury but not toxic mesenteric lymph nor lung injury.
Sharpe SM; Qin X; Lu Q; Feketeova E; Palange DC; Dong W; Sheth SU; Lee MA; Reino D; Xu DZ; Deitch EA
Shock; 2010 Nov; 34(5):475-81. PubMed ID: 20220565
[TBL] [Abstract][Full Text] [Related]
25. Oral drug absorption enhancement by chitosan and its derivatives.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):117-26. PubMed ID: 11718935
[TBL] [Abstract][Full Text] [Related]
26. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1346-56. PubMed ID: 17380268
[TBL] [Abstract][Full Text] [Related]
27. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation.
Jonker C; Hamman JH; Kotzé AF
Int J Pharm; 2002 May; 238(1-2):205-13. PubMed ID: 11996824
[TBL] [Abstract][Full Text] [Related]
28. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport.
Behrens I; Pena AI; Alonso MJ; Kissel T
Pharm Res; 2002 Aug; 19(8):1185-93. PubMed ID: 12240945
[TBL] [Abstract][Full Text] [Related]
29. In vitro absorption studies with carvedilol using a new model with porcine intestine called BM-RIMO (Boehringer-Mannheim ring model).
Nolte K; Backfisch G; Neidlein R
Arzneimittelforschung; 1999 Sep; 49(9):745-9. PubMed ID: 10514901
[TBL] [Abstract][Full Text] [Related]
30. 5β-Cholanic Acid/Glycol Chitosan Self-Assembled Nanoparticles (5β-CHA/GC-NPs) for Enhancing the Absorption of FDs and Insulin by Rat Intestinal Membranes.
Yan C; Gu J; Lv Y; Shi W; Huang Z; Liao Y
AAPS PharmSciTech; 2019 Jan; 20(1):30. PubMed ID: 30603934
[TBL] [Abstract][Full Text] [Related]
31. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability.
Kamei N; Yamanaka J; Oda Y; Kaneoka S; Koide Y; Haruna Y; Takahashi Y; Tamiwa H; Takeda-Morishita M
Pharm Res; 2020 Sep; 37(10):182. PubMed ID: 32888051
[TBL] [Abstract][Full Text] [Related]
33. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
34. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luessen HL; de Boer BG; Verhoef JC; Junginger HE
Eur J Pharm Biopharm; 1999 May; 47(3):269-74. PubMed ID: 10382111
[TBL] [Abstract][Full Text] [Related]
35. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
36. Effect of salt forms and molecular weight of chitosans on in vitro permeability enhancement in intestinal epithelial cells (Caco-2).
Opanasopit P; Aumklad P; Kowapradit J; Ngawhiranpat T; Apirakaramwong A; Rojanarata T; Puttipipatkhachorn S
Pharm Dev Technol; 2007; 12(5):447-55. PubMed ID: 17963144
[TBL] [Abstract][Full Text] [Related]
37. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2).
Artursson P; Lindmark T; Davis SS; Illum L
Pharm Res; 1994 Sep; 11(9):1358-61. PubMed ID: 7816770
[No Abstract] [Full Text] [Related]
38. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
[TBL] [Abstract][Full Text] [Related]
39. Influence of morphometric factors on quantitation of paracellular permeability of intestinal epithelia in vitro.
Collett A; Walker D; Sims E; He YL; Speers P; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1997 Jun; 14(6):767-73. PubMed ID: 9210195
[TBL] [Abstract][Full Text] [Related]
40. Effects of various absorption enhancers on transport of clodronate through Caco-2 cells.
Raiman J; Törmälehto S; Yritys K; Junginger HE; Mönkkönen J
Int J Pharm; 2003 Aug; 261(1-2):129-36. PubMed ID: 12878401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
